Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Exclusive-Drugmakers raise US prices on 350 medicines despite pressure from Trump - 2Vote In favor of Your Favored Sort Of Dress
- 3What to know about King Charles III's cancer treatment and his message to the public
- 4Become the best at Discussion: 6 Procedures for Progress
- 5Ancient fire discovery marks significant milestone in human history
- Which European palace do you fantasy about visiting? Vote!
- Favored Vehicle for Seniors: Make Your Determination
- Vote in favor of Your #1 Instructive Toy: Learning and Tomfoolery Joined
- Discussion on deployment of foreign troops ongoing, two sources tell 'Post'
- Vote In favor of Your Favored Occasion Arranging Administration
- Best Getaway destination: Ocean side, Mountain, or City
- Find the Wonders of the Silk Street: Following the Antiquated Shipping lanes
- Get Cooking: 15 Speedy and Heavenly Recipes for Occupied Individuals
- Flash flooding causes highways to close to and from Eilat
